Meeting

The first meeting of the committee took place on March 3-4, 2008. It was open to the public on Monday, March 3rd from 1:00 p.m. to approximately 6:00 p.m. in the Lecture Room of the National Academies of Sciences Building, 2100 C Street, NW, Washington, DC.

1:00 pm Welcome and Committee Introductions
Claire V. Broome
Committee Chair

1:10 – 1:20 pm
Anand Parekh
Acting Deputy Assistant Secretary for Health
(Science and Medicine)
Office of the Assistant Secretary for Health
Department of Health and Human Services

1:20 – 1 :50 pm
Update of The National Vaccine Plan
CAPT Raymond A. Strikas
Medical Officer
U.S. Public Health Service
National Vaccine Program Office
Department of Health and Human Services

1:50 – 2:05 pm Questions from the Committee

2:05 – 3:05 pm Key Dimensions of The National Vaccine Plan: Since 1994 and Future
Melinda Wharton
Deputy Director
National Center for Immunizations and Respiratory Diseases
Centers for Disease Control and Prevention

Norman Baylor
Director
Office of Vaccines Research and Review
Center for Biologics Evaluation
Food and Drug Administration

Carole A. Heilman
Director
Division of Microbiology and Infectious Diseases
National Institute of Allergy and Infectious Diseases
National Institutes of Health

3:05 – 3:20 pm Questions from the Committee

3:20 – 3:30 pm Break

3:30 – 4:10 pm Key Dimensions of The National Vaccine Plan, continued
Jeffrey Kelman
Chief Medical Officer
Center for Beneficiary Choices
Centers for Medicare and Medicaid Services

Geoffrey Evans
Director
Division of Vaccine Injury Compensation
Healthcare Systems Bureau
Health Resources and Services Administration

Jerome Donlon
Chief Scientist Advisor & Medical Officer, Office of the Assistant Secretary for Public Health Emergency Preparedness
Department of Health and Human Services

Ellyn Ogden
Health Development Officer
US Agency for International Development

4:10 – 4:30 pm Questions from the Committee

4:30 – 4: 45 pm Relationship Between the National Vaccine Plan and Healthy People 2020
RADM Penelope Slade Royall
Director
Office of Disease Prevention and Health Promotion
Office of Public Health and Science, Office of the Secretary
Department of Health and Human Service

4:45 – 5:15 pm Status of the New National Vaccine Plan

Draft Priorities for the National Vaccine Plan
Walter Orenstein
Professor of Medicine and Pediatrics
Emory University School of Medicine
Deputy Director, Emory Vaccine Center
Consultant to the National Vaccine Plan

Results of the first focus groups for public engagement
Richard Tardif
Oak Ridge Institute for Science and Education (ORISE)
Consultant to the National Vaccine Plan

Future Plans for Public engagement
Roger Bernier
Centers for Disease Control and Prevention

5:15 – 5:30 pm Questions from the Committee

5:30 – 5:40 pm Public comments

5:45 p.m.
Adjourn